Evolution Summit 2021 - Boston | Marcus Evans Summits | 21 September 2021 | Encore Boston Harbor, 1 Broadway, Everett, MA 02149, USA

The Evolution Summit is an invitation-only, premium Summit bringing leading clinical trial executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.

Key Topics for 2021:
• Committing to diversity and inclusion in clinical trials through the implementation of proven initiatives
• Adapting to the new reality in a post-COVID world and charting the course for the pandemic aftermath
• Incorporating lessons learnt over the past year to propel forward and break down barriers to decentralized trials
• Driving patient centricity beyond the pandemic and embedding a patient-centric vision throughout the entire organization
• Fostering collaborative efforts between the sponsor, site and CRO to create a means of developing proactive approaches to maintaining a state of readiness
• Techniques for efficient and effective communication with KOLs and strategies to educate and support clinical trial sites

2021 Speakers

SPEAKERS:

Craig Lipset
Co-Chair, The Decentralized Trials & Research Alliance and Former Head of Clinical Innovation, Pfizer

Rose Gerber
Director, Patient Advocacy and Education, Community Oncology Alliance (COA)

COMPELLING PRESENTATIONS:

Rosanne Petros
Associate Director, Clinical Research, Merck

Jim Frantantonio, PharmD
Medical Director, Medical Affairs Strategy, Alkermes, Inc.

Behtash Bahador, MS
Associate Director, Relationship Management and Development, Center for Information & Study on Clinical Research Participation (CISCRP)

Natalie Artzi
Assistant Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School; Principal Research Scientist, MIT; Associate Member, Broad Institute of Harvard and MIT

James Dahlman
Assistant Professor, Georgia Tech / Emory Med School

Chad Swanson
Executive Director, Clinical Research, Neurology Business Group, Eisai, Inc.

INTERACTIVE SESSIONS:

Sharon Crugnale
Head, Clinical Operations, Sarepta Therapeutics

Kate Tranotti
Senior Director, Global Head Clinical Operations-NBG, Eisai

Marisa Rackley
Global Head Study Start Up and Site Strategy, Vertex Pharmaceuticals

Steven Chen
Chief Medical Officer, Avelas Bio

Anita DiFrancesco
VP, Clinical Operations, Endeavor Biomedicines

Surabhi Sharma
Executive Director, Program and Portfolio Management, Caladrius Biosciences

Michael Ropacki
Chief Medical Officer, CNS, Oryzon

Elisabeth Kurkimilis
Senior Director, Global Clinical Trials, Prometheus Biosciences

Prajna Kumar
Senior Director, Clinical Development Quality Operations, Alexion, AztraZeneca Rare Disease

Betel Girmay
Director, Global Clinical Operations, Alexion, AztraZeneca Rare Disease

Casey Orvin
Honorary President, The Society for Clinical Research Sites

2021 Sponsors

• PharmaVision
• Clinical Research Informer
• PharmaVoice